Latest Schedule 13G passive stakes

GIC Private Limited and its affiliates have reported beneficial ownership of less than 5% of Clarivtev Corporation's Class A Common Stock.

Chien-Fu Chen Chen has filed a Schedule 13G, reporting beneficial ownership of 17.6% of Ticketplus Ltd.'s ordinary shares as of September 30, 2026.

Yethro Dinamarca Santelices has filed a Schedule 13G, reporting beneficial ownership of 7,756,267 ordinary shares, representing 60.7% of Ticketplus Ltd.

Commodore Capital LP, along with affiliated entities, has reported beneficial ownership of 885,000 shares, representing 7.5% of Surrozen, Inc.'s common stock.

Frasers Group plc and associated entities have filed a Schedule 13G, reporting beneficial ownership of 8.8% of Under Armour's Class A Common Stock.

L1 Capital Global Opportunities Master Fund, Ltd. has reported beneficial ownership of 9.99% of Baird Medical Investment Holdings Ltd.'s ordinary shares, primarily through convertible notes.

ForGrowth III PA B.V., along with affiliated entities, reports beneficial ownership of 5,248,841 shares, representing 5.1% of Aura Biosciences' common stock.

Paradigm BioCapital Advisors LP, along with affiliated entities, has reported beneficial ownership of 5.1% of Spyre Therapeutics, Inc. common stock.

Pale Fire Capital and associated entities have reported beneficial ownership of 5.1% of Lightspeed Commerce Inc.'s subordinate voting shares.

SIT Investment Associates and its subsidiary SIT Fixed Income Advisors II, LLC are transitioning back to a Schedule 13G filing, indicating their holdings are no longer intended to influence or control the issuer.

Iridian Asset Management LLC has filed a Schedule 13G, disclosing beneficial ownership of 919,498 shares of Katapult Holdings, Inc., representing 1.08% of the class.

Larry M. Walther has filed a Schedule 13G, reporting beneficial ownership of 512,000 shares, representing 9.8% of the common stock of Arts Way Manufacturing Co., Inc.

Sit Investment Associates and Sit Fixed Income Advisors II LLC are transitioning back to a Schedule 13G filing, indicating they no longer hold securities with the intent to influence control.

Sit Investment Associates and Sit Fixed Income Advisors II LLC are transitioning back to a Schedule 13G filing for their holdings in Aberdeen Intermediate Income Fund, indicating no intent to influence control.

Sit Investment Associates and its subsidiary Sit Fixed Income Advisors II, LLC are transitioning back to a Schedule 13G filing for Aberdeen Government Markets Income Fund, indicating their holdings are no longer intended to influence control.

Sit Investment Associates and Sit Fixed Income Advisors II, LLC are transitioning back to a Schedule 13G filing for DWS Municipal Income Trust, indicating a change in their investment intent away from influencing control.

SIT Investment Associates and its subsidiary SIT Fixed Income Advisors II, LLC are transitioning back to a Schedule 13G filing for First Trust Mortgage Income Fund, indicating a change in their investment intent.

Sit Investment Associates and Sit Fixed Income Advisors II are transitioning back to a Schedule 13G filing for Eaton Vance Ltd Duration Income Fund, indicating a change in investment intent away from influencing control.

Sit Investment Associates and its subsidiary Sit Fixed Income Advisors II are transitioning their SEC filing for Eaton Vance Short Duration Diversified Income Fund from a Schedule 13D back to a Schedule 13G, indicating a change in investment intent.

Wolf Hill Capital Management, LP, along with affiliated entities and Gary Lehrman, has reported a change in their beneficial ownership of Camping World Holdings, Inc. Class A Common Stock.

Allen Kronstadt has filed a Schedule 13G, disclosing beneficial ownership of 213,750 shares, representing 7.9% of the outstanding common stock of Brightline Interactive, Inc./NV.

Mink Brook entities and William Mueller report beneficial ownership of 6.0% of Legacy Education Inc. common stock.

Russell Paul Newton has reported beneficial ownership of 15,275,251 ordinary shares, representing 11.6% of CoinShares PLC, through direct holdings and controlled entities.

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported beneficial ownership of 6,343,651 shares, representing 5.4% of Indivior Pharmaceuticals, Inc.'s common stock.

Several Biotechnology Value Fund entities and Mark N. Lampert have filed a Schedule 13G, reporting changes in their beneficial ownership of Stoke Therapeutics, Inc. common stock.

i3 Verticals, Inc. sees its major stakeholders, Forager Capital Management, LLC, Forager Fund, L.P., Edward Kissel, and Robert MacArthur, jointly filing a Schedule 13G to report beneficial ownership of 6.1% of the company's Class A Common Stock.

Millennium Management LLC, along with affiliated entities and Israel A. Englander, has reported beneficial ownership of 5.1% of AMERISAFE, Inc. common stock.

Citadel entities, including Citadel Securities and Citadel Advisors, have reported beneficial ownership of IREN Limited shares, totaling up to 4.7%.

Portolan Capital Management, LLC, along with its manager George McCabe, has disclosed beneficial ownership of 5.06% of Silicom Ltd.'s ordinary shares.

Glazer Capital, LLC and Paul J. Glazer have reported beneficial ownership of 5,969,101 shares, representing 5.0% of Accelerant Holdings' common stock.